NCCN practice guidelines for fever and neutropenia

ONCOLOGY

Volumn 13, Issue 5 A, 1999, Pages 197-257

  Rubenstein, E ^a   Wade, J C ^a   Adams, P ^a   Brown, A ^a   Elting, L ^a   Finberg, R ^a   Greene, J ^a   King, E ^a   Lipman, B ^a   Mendez, P ^a   Miller, C B ^a   Montoya, J ^a   Noskin, G ^a   Reed, E ^a   Rolston, K ^a   Talcott, J ^a   Zabner, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ATOVAQUONE; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; FAMCICLOVIR; FLUCONAZOLE; FLUDARABINE; FOSCARNET; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MEROPENEM; PENTAMIDINE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; UREIDOPENICILLIN; VANCOMYCIN;

ALGORITHM; ANTIBIOTIC THERAPY; CANCER PATIENT; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OTOTOXICITY; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; FEVER; HUMANS; NEUTROPENIA; VANCOMYCIN;

EID: 0033003173     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)